Concepedia

Post-neoadjuvant Therapy

Post-Neoadjuvant Therapy is a therapeutic intervention strategy classified as a sequential treatment regimen in systemic breast cancer management, specifically administered after the completion of neoadjuvant therapy to target residual disease and reduce the risk of recurrence.

911

Publications

64.4K

Citations

6.5K

Authors

1.8K

Institutions

Publications per year

2017–2026

404

Parents

Publications

911

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Aron Goldhirsch, Eric P. Winer, Alan S. Coates et al. · Annals of Oncology · 2013 · 3.7K citations · Full text

, , +10

Pembrolizumab for Early Triple-Negative Breast Cancer

Peter Schmid, Javier Cortés, Lajos Pusztai et al. · New England Journal of Medicine · 2020 · 3.1K citations · Full text

, , +16

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

Gϋnter von Minckwitz, Michael Untch, Jens‐Uwe Blohmer et al. · Journal of Clinical Oncology · 2012 · 2.7K citations

, , +15

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Luca Gianni, Tadeusz Pieńkowski, Young‐Hyuck Im et al. · The Lancet Oncology · 2011 · 2.4K citations

, , +16

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

Luca Gianni, W. Eiermann, Alexey Manikhas et al. · The Lancet · 2010 · 1.3K citations

, , +16

1–5 of 911

Authors

6.5K

  1. GN
    Gabriel N. Hortobágyi

    The University of Texas MD Anderson Cancer Center, United States

    31 publications · 3.6K citations

    25

    h-index

  2. MU
    Michael Untch

    Helios Hospital Berlin-Buch, Germany

    39 publications · 11.3K citations

    23

    h-index

  3. SL
    Sibylle Loibl

    German Breast group, Germany

    36 publications · 8.5K citations

    23

    h-index

  4. GV
    Gϋnter von Minckwitz

    German Breast group, Germany

    34 publications · 5.4K citations

    20

    h-index

  5. VV
    Vicente Valero

    The University of Texas MD Anderson Cancer Center, United States

    26 publications · 3.1K citations

    20

    h-index

1–5 of 6.5K

Institutions

1.8K

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    47 h-index

    562 publications

    64.3K citations

  2. Memorial Sloan Kettering Cancer Center

    New York, United States

    24 h-index

    113 publications

    13.4K citations

  3. German Breast group

    Offenbach, Germany

    22 h-index

    95 publications

    7.2K citations

  4. Helios Hospital Berlin-Buch

    Berlin, Germany

    20 h-index

    33 publications

    5K citations

  5. Mayo Clinic

    Rochester, United States

    20 h-index

    98 publications

    9.5K citations

  6. Mayo Clinic in Arizona

    Scottsdale, United States

    20 h-index

    94 publications

    7.2K citations

  7. Charité - Universitätsmedizin Berlin

    Berlin, Germany

    19 h-index

    63 publications

    3.2K citations

  8. Institut Curie

    Paris, France

    19 h-index

    138 publications

    8.2K citations

1–8 of 1.8K

Venues

  1. Annals of Surgical Oncology

    64 publications · 3.7K citations

    35

    h-index

  2. Breast Cancer Research and Treatment

    92 publications · 4.2K citations

    34

    h-index

  3. Annals of Oncology

    48 publications · 7K citations

    31

    h-index

  4. Journal of Clinical Oncology

    38 publications · 9.2K citations

    26

    h-index

  5. Clinical Breast Cancer

    31 publications · 835 citations

    19

    h-index

1–5